BIOLINERX LTD's ticker is BLRX and the CUSIP is 09071M205. A total of 30 filers reported holding BIOLINERX LTD in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $319,887 | -23.2% | 175,762 | -32.7% | 0.00% | – |
Q2 2023 | $416,257 | +82.8% | 260,976 | +1.6% | 0.00% | – |
Q1 2023 | $227,753 | +52.6% | 256,912 | +1.6% | 0.00% | – |
Q4 2022 | $149,242 | -38.6% | 252,952 | -3.7% | 0.00% | – |
Q3 2022 | $243,000 | -24.8% | 262,559 | +4.1% | 0.00% | – |
Q2 2022 | $323,000 | -30.4% | 252,184 | -7.1% | 0.00% | – |
Q1 2022 | $464,000 | -12.6% | 271,535 | +4.4% | 0.00% | – |
Q4 2021 | $531,000 | -19.5% | 260,166 | +8.3% | 0.00% | – |
Q3 2021 | $660,000 | +3.6% | 240,128 | +5.9% | 0.00% | – |
Q2 2021 | $637,000 | -42.7% | 226,822 | -43.1% | 0.00% | – |
Q1 2021 | $1,112,000 | -39.7% | 398,412 | -45.6% | 0.00% | – |
Q4 2020 | $1,845,000 | +46.4% | 732,191 | -4.7% | 0.00% | – |
Q3 2020 | $1,260,000 | +30.4% | 768,335 | +36.0% | 0.00% | – |
Q2 2020 | $966,000 | +111.4% | 565,114 | +64.3% | 0.00% | – |
Q1 2020 | $457,000 | -20.7% | 343,909 | +34.3% | 0.00% | – |
Q4 2019 | $576,000 | +50.0% | 255,987 | +76.1% | 0.00% | – |
Q3 2019 | $384,000 | – | 145,382 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 1,686,375 | $2,884,000 | 0.18% |
Senvest Management, LLC | 451,205 | $772,000 | 0.05% |
Cutter & CO Brokerage, Inc. | 17,799 | $30,000 | 0.01% |
Opaleye Management Inc. | 16,667 | $29,000 | 0.01% |
Psagot Value Holdings Ltd. | 117,000 | $200,000 | 0.01% |
Orbimed Advisors | 69,240 | $118,000 | 0.00% |
MORGAN STANLEY | 565,114 | $966,000 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 18,973 | $32,000 | 0.00% |
LPL Financial LLC | 19,876 | $34,000 | 0.00% |
Asset Dedication, LLC | 366 | $1,000 | 0.00% |